// Definition
The tension between pharmaceutical companies seeking to patent and control cannabinoid medicines and the grassroots cannabis community that has been producing and distributing cannabis products for decades.
// From the Episode
A major discussion in episode 061 centered on the dual economics of cannabis — recreational prices driving down while pharmaceutical companies recognize the medical value and try to drive prices up. Todd McCormick argued that cannabis is too easy to produce for pharma to monopolize, citing his own experience growing in his grandmother's closet. The panel emphasized that people like Bubbleman who separate cannabinoids and terpenes and make them available undermine pharma's ability to claim exclusive control.
// Source
Ep. 061 Hash Church LXI 61 →